tiprankstipranks
Trending News
More News >
Evogene (EVGN)
NASDAQ:EVGN
US Market
Advertisement

Evogene (EVGN) Financial Statements

Compare
629 Followers

Evogene Financial Overview

Evogene's market cap is currently $11.94M. The company's EPS TTM is $-0.38; its P/E ratio is ―; Evogene is scheduled to report earnings on May 21, 2025, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 8.51M$ 5.64M$ 1.68M$ 930.00K$ 1.04M
Gross Profit$ 5.83M$ 1.40M$ 766.00K$ 163.00K$ 466.00K
Operating Income$ -22.21M$ -26.39M$ -26.94M$ -30.95M$ -24.81M
EBITDA$ -15.48M$ -23.20M$ -26.93M$ -27.80M$ -23.18M
Net Income$ -16.48M$ -23.88M$ -26.64M$ -27.79M$ -23.37M
Balance Sheet
Cash & Short-Term Investments$ 15.31M$ 31.06M$ 35.35M$ 53.87M$ 48.23M
Total Assets$ 39.86M$ 51.10M$ 56.13M$ 76.30M$ 71.92M
Total Debt$ 12.87M$ 11.51M$ 11.93M$ 2.67M$ 2.44M
Net Debt$ -2.43M$ -9.27M$ -17.05M$ -29.66M$ -43.79M
Total Liabilities$ 25.03M$ 22.42M$ 21.34M$ 12.88M$ 15.03M
Stockholders' Equity$ -1.45M$ 12.05M$ 27.93M$ 54.03M$ 46.05M
Cash Flow
Free Cash Flow$ -20.33M$ -22.36M$ -24.85M$ -25.56M$ -20.20M
Operating Cash Flow$ -19.70M$ -21.58M$ -23.68M$ -24.84M$ -19.51M
Investing Cash Flow$ 9.62M$ -4.54M$ 13.27M$ -20.44M$ 9.41M
Financing Cash Flow$ 4.66M$ 18.15M$ 9.34M$ 30.28M$ 20.37M
Currency in USD

Evogene Earnings and Revenue History

Evogene Debt to Assets

Evogene Cash Flow

Evogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis